Search alternatives:
small decrease » small increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
small decrease » small increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
1
DataSheet1_Decreasing viscosity and increasing accessible load by replacing classical diluents with a hydrotrope in liquid–liquid extraction.docx
Published 2025“…We show that using hydrotropes as a diluent decreases the viscosity of solutions by more than a factor of ten, even under high load by extracted cations. …”
-
2
-
3
-
4
-
5
Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane
Published 2025Subjects: -
6
Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane
Published 2025Subjects: -
7
Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane
Published 2025Subjects: -
8
Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane
Published 2025Subjects: -
9
Dynamic Covalent Chemistry Enabled Closed-Loop Recycling of Thermally Modified Polymer Membrane
Published 2025Subjects: -
10
Candidates from the RF method. The top 25 random forest candidates ranked by mean decrease in accuracy and mean decrease in Gini Index are in the first and second columns, respectively....
Published 2025“…The top 25 random forest candidates ranked by mean decrease in accuracy and mean decrease in Gini Index are in the first and second columns, respectively. …”
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc
Published 2025“…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
-
19
-
20